Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: Quality control procedures

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 6, 1998, Pages 755-761

  Aziz, Najib ^a   Nishanian, Parunag ^a   Fahey, John L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY CONTROL; VIRUS INFECTION;

EID: 0031773989     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.6.755-761.1998     Document Type: Article

References (49)

1. Aggarwal, B. B., and R. K. Puri. 1995. Common and uncommon features of cytokines and cytokine receptors: an overview, p. 3-24. In B. B. Aggarwal and R. K. Puri (ed.), Human cytokines: their role in disease and therapy. Blackwell Science, Cambridge, Mass.
2. Aukrust, P., N. B. Liabakk, F. Müller, E. Lien, T. Espevik, and S. S. Froland. 1994. Serum levels of tumor necrosis factor-alpha (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection: correlations to clinical immunologic and virologic parameters. J. Infect. Dis. 169:420-424.
3. Bass, H. Z., P. Nishanian, W. D. Hardy, R. T. Mitsuyasu, E. Esmail, W. Cumberland, and J. L. Fahey. 1992. Immune changes in HIV infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin. Immunol. Immunopathol. 64:63-70.
4. Bienvenu, J., L. Coulon, C. Doche, M. C. Gutowski, and G. Grau. 1993. Analytical performances of commercial ELISA kits for IL-2, IL-6 and TNFα. A WHO study. Eur. Cytokine Netw. 4:447-451.
5. Cannon, J. G., J. L. Nerad, D. D. Poutsiaka, and C. A. Dinarello. 1993. Measuring circulating cytokines. J. Appl. Physiol. 75:1897-1902.
6. Choi, S., S. W. Lagakos, R. T. Schooley, and P. A. Volberding. 1993. CD4 lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann. Intern. Med. 118:674-680.
7. De Kossodo, S., V. Houba, G. E. Grau, and WHO Collaborative Study Group. 1995. Assaying tumor necrosis factor concentrations in human serum. A WHO international collaborative study. J. Immunol. Methods 182:107-114.
8. de Wolf, F., I. Spijkerman, P. T. Schellekens, M. Langendam, C. Kuiken, M. Bakker, M. Roos, R. Coutinho, F. Miedema, and J. Goudsmit. 1997. AIDS prognosis based on HIV-1 RNA, CD4+ T cell count and function: markers with reciprocal predictive value over time after seroconversion. AIDS 11: 1799-1806.
9. Exley, A. R., and J. Cohen. 1990. Optimal collection of blood samples for the measurement of tumor necrosis factor-alpha. Cytokine 2:353-356.
10. Fahey, J. L. 1998. Cytokines, plasma immune activation markers, and cally relevant surrogate markers in human immunodeficiency virus infection. Clin. Diagn. Lab. Immunol. 5:597-603.
11. Fahey, J. L., J. M. G. Taylor, R. Detels, B. Hofmann, R. Melmed, P. Nishanian, and J. V. Giorgi. 1990. The prognostic value of cellular and serological markers in infection with human immunodeficiency virus type 1. N. Engl. J. Med. 322:166-172.
12. Fahey, J. L., J. M. G. Taylor, B. Manna, P. Nishanian, N. Aziz, J. V. Giorgi, and R. Detels. 1998. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS 12:1581-1590.
13. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529-534.
14. Federal Register. 1992. Clinical laboratory improvement amendments of 1988; final rules and notice. Fed. Regist. 42CFR:7188-7243.
15. Fuchs, D., H. Jager, M. Popescu, G. Reibnegger, E. R. Werner, M. P. Dierich, W. Kaboth, G. P. Tilz, and H. Wachter. 1990. Immune activation markers to predict AIDS and survival in HIV-1 seropositives. Immunol. Lett. 26:75-80.
16. Gaines-Das, R. E., and S. Poole. 1993. The international standard for interleukin-6. Evaluation in an international collaborative study. J. Immunol. Methods 160:147-153.
17. Gearing, A. J. H., J. E. Cartwright, and M. Wadhwa. 1991. Biological and immunological assays for cytokines, p. 339-355. In A. Thomson (ed.), The cytokine handbook. Academic Press, London, England.
18. Giorgi, J. V., H.-L. Cheng, J. B. Margolick, K. D. Bauer, J. Ferbas, M. Waxdal, I. Schmid, L. E. Hultin, A. L. Jackson, L. Park, J. M. G. Taylor, and Multicenter AIDS Cohort Study Group. 1990. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. Clin. Immunol. Immunopathol. 55:173-186.
19. Hoekman, K., J. A. Van-Nieuwkoop, and R. Willemze. 1985. The significance of beta-2 microglobulin in clinical medicine. Neth. J. Med. 28:551-557.
20. Hofmann, B., H. Bass, P. Nishanian, M. Faisal, R. A. Figlin, G. P. Sarna, and J. L. Fahey. 1992. Different lymphoid cell populations produce varied levels of neopterin, β2-microglobulin and soluble IL-2 receptor when stimulated with IL-2. interferon-gamma or tumor necrosis factor-alpha. Clin. Exp. Immunol. 88:548-554.
21. Hofmann, B., Y. X. Wang, W. G. Cumberland, R. Detels, M. Bozorgmehri, and J. L. Fahey. 1990. Serum β2-microglobulin level increases in HIV-1 infection: relation to seroconversion, CD4 T cell fall and prognosis AIDS 4:207-214.
22. Howanitz, P. J., and J. H. Howanitz. 1987. Laboratory quality assurance, p. 1-54. McGraw-Hill, New York, N. Y.
23. Huber, C., J. R. Batchelor, D. Fuchs, A. Hausen, A. Lang, and D. Nierderwieser. 1984. Immune response-associated production of neopterin: release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 160:310-316.
24. Kapadia, S., G. Torre-Amione, and D. L. Mann. 1994. Pitfalls in measuring cytokines. Ann. Intern. Med. 121:149-150.
25. Kaslow, R. A., D. G. Ostrow, R. Detels, J. P. Phair, B. F. Polk, and C. R. Rinaldo, Jr. 1987. The multicenter AIDS cohort study: rationale, organization and selected characteristics of the participants. Am. J. Epidemiol. 126:310-318.
26. Ledur, A., C. Fitting, B. David, C. Hamberger, and J.-M. Cavaillon. 1995. Variable estimates of cytokine levels produced by commercial ELISA kits improved results using international cytokine standards. J. Immunol. Methods 186:171-179.
27. Leroux-Roels, G., F. Offner, J. Philippe, and A. Vermeulen. 1988. Influence of blood-collecting systems on concentrations of tumor necrosis factor in serum and plasma. Clin. Chem. 34:2373-2374.
28. Melmed, R. N., J. M. G. Taylor, R. Detels, M. Bozorgmehri, and J. L. Fahey. 1989. Serum neoptcrin changes in HIV-1 infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS. J. Acquired Immune Defic. Syndr. 2:70-76.
29. Mire-Sluis, A. K. 1993. Cytokines-protein structure and biological activity: a complex relationship with implication for biological assays and standardization. Biologicals 21:131-144.
30. Mire-Sluis, A. R., R. Gaines-Das, and R. Thorpe. 1995. Immunoassays for detecting cytokines: what are they really measuring? J. Immunol. Methods 186:157-160.
31. Mire-Sluis, A. R., R. Gaines-Das, R. Thorpe, and Participants of the Collaborative Study. 1995. The international standard for macrophage colony stimulating factor (M-CSF) - evaluation in an international collaborative study. J. Immunol. Methods 179:141-151.
32. Mire-Sluis, A. R., R. Gaines-Das, R. Thorpe, and Participants of the Collaborative Study. 1995. The international standard for granulocyte-macrophage colony stimulating factor (GM-CSF) - evaluation in an international collaborative study. J. Immunol. Methods 179:127-135.
33. Mire-Sluis, A. R., R. Gaines-Das, R. Thorpe, and Participants of the Collaborative Study. 1997. Implications for the assay and biological activity of interleukin-8. J. Immunol. Methods 200:1-16.
34. Nishanian, P., J. M. G. Taylor, B. Manna, N. Aziz, S. Grosser, J. V. Giorgi, R. Detels, and J. L. Fahey. 1998. Accelerated changes (inflection points) in levels of serum immune activation markers and CD4+ and CD8+ T cells prior to AIDS onset. J. Acquired Immune Defic. Syndr. 18:162-170.
35. Osmond, D. H., S. Shiboski, P. Bacchetti, E. E. Winger, and A. R. Moss. 1991. Immune activation markers and AIDS prognosis. AIDS 5:505-511.
36. Pesce, A. J., and J. G. Michael. 1992. Artifacts and limitations of enzyme inimunoassays. J. Immunol. Methods 150:111-119.
37. Petyovka, N., L. Lyach, and N. N. Voitenok. 1995. Homologous ELISA for detection of oligomeric human TNF: properties of assay. J. Immunol. Methods 186:161-170.
38. Plaeger, S., H. Z. Bass, P. Nishanian, J. Thomas, N. Aziz, R. Detels, J. King, W. Cumberland, M. Kemeny, and J. L. Fahey. The prognostic significance of HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes. Clin. Immunol. Immunopathol., in press.
39. Poli, G., and A. S. Fauci. 1995. Role of cytokines in the pathogenesis of human immunodeficiency virus infection, p. 421-450. In B. B. Aggarwal and R. K. Puri (ed.), Human cytokines: their role in disease and therapy. Blackwell Science, Cambridge, Mass.
40. Poole, S., and R. E. Gaines-Das. 1991. The international standards for IL-1α and IL-1β. Evaluation in an international collaborative study. J. Immunol. Methods 142:1-13.
41. Riches, P., R. Gooding, B. C. Millar, and A. W. Rowbottom. 1992. Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-α concentrations. J. Immunol. Methods 153:125-131.
42. H2 cytokine in HIV infection. Immunol. Rev. 140:73-92.
43. Rubin, L. A., C. C. Kurman, M. E. Fitz, and B. Boutin. 1985. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 135:3172-3177.
44. Salazar-Gonzalez, J. F., O. Martinez-Maza, P. Nishanian, N. Aziz, L.-P. Shen, S. Grosser, J. M. G. Taylor, R. Detels, and J. L. Fahey. Increased immune activation precedes the inflection point of CD4+ T cells and the increased serum viral load in HIV infection. J. Infect. Dis., in press.
45. Thavasu, P. W., S. Longhurst, S. P. Joel, M. L. Slevin, and F. R. Balkwill. 1992. Measuring cytokine levels in blood: importance of anticoagulants, processing and storage conditions. J. Immunol. Methods 153:115-124.
46. Thorpe, R., M. Wadhwa, C. R. Bird, and A. R. Mire-Sluis. 1992. Detection and measurement of cytokines. Blood Rev. 6:133-148.
47. Tsoukas, C. M., and N. F. Bernard. 1994. Markers predicting progression of human immunodeficiency virus-related disease. Clin. Microbiol. Rev. 7:14-28.
48. Wachter, H., D. Fuchs, A. Hausen, G. Reibnegger, and E. R. Werner. 1989. Neopterin as a marker for activation of cellular immunity: immunologic basis and clinical application. Adv. Clin. Chem. 27:81-141.
49. Whicher, J., and E. Ingham. 1990. Cytokine measurements in body fluids. Eur. Cytokine Netw. 1:239-243.